HIT-HARD Trial Protocol Tests Short-Course High-Dose Antibiotics
The HIT-HARD trial protocol outlines a phase III study testing if short-course, high-dose beta-lactam therapy is non-inferior to conventional regimens ...
The HIT-HARD trial protocol outlines a phase III study testing if short-course, high-dose beta-lactam therapy is non-inferior to conventional regimens ...
A multicentre randomised trial is testing whether an oral bacterial lysate can reduce recurrent wheezing episodes in infants following hospitalisation ...
A phase II multicentre study protocol evaluates the feasibility of combining neoadjuvant intraperitoneal irinotecan with systemic therapy prior to cytoreductive ...
A multicenter clinical trial protocol outlines a randomized factorial study evaluating whether transcutaneous electrical acupoint stimulation at the P6 acupoint ...
A new trial protocol in the Basque Health Service plans to test if pharmacist-led facilitation can enhance audit and feedback ...
A new phase 2a trial protocol aims to evaluate the pharmacokinetics and safety of empagliflozin in children with Duchenne muscular ...
A randomized controlled trial in Ireland will test whether a high-fibre, fermented-food diet targeting the gut microbiota can reduce ADHD ...
A newly published protocol details ACO-SWITCH, a phase 4 single-arm study that will measure serum transthyretin changes in 50 adults ...
A new phase II trial protocol will test whether AGuIX nanoparticles, already shown to be tolerated at 100 mg/kg in ...
A published protocol details the first randomised, placebo-controlled trial testing whether the oral drug PXS-4728A reduces PET-measured brain neuroinflammation in ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine